"Stepped back, took a look, saw a pimple on an elephants arse....just saying."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your gainers seem to be out pacing your losers, good job! I need to pay closer attention.
Thanks!
Come help support me on the bid folks.....
Appreciate the responce, thanks.
I would like to know how all the other miners in the area are dealing with their water problem or is PCFG problem unique? Thanks.
Was thinking that too. Thanks
Just a reminder all you expert traders out there....Buy something that you believe in that has value (gold) when everyone is selling and negativity is at it's peak. Almost there. And of course on the other side of the coin sell it when they are screaming buy, buy, buy.
The vultures are lining up at .015 - me too.
Very quiet indeed... I hope this onslaught of good news is not just a once off thing followed by silence again. It looks like more good news is going to have to follow to get the herd interested.
After watching this stock for about two years and a couple of small successful trades something just does not add up and I say this with absolutely no disrespect to anyone.
On the other hand I have been noticing on many small cap stocks lately the "market" has vastly undervalued these stocks until some major event happens then boom, massive increase in share price in a fraction of time.
Still considering taking a position in MHTX.
Sold TSPT for a tidy little 5% profit, I will take these kinds of trades all day long.
So quiet and peaceful here now, kind of tells me that the selling is about done and time to accumulate a little again.
Is it just me seeing this more and more? Small companies that the "market" has just no clue how to value, until an event happens.
Wow the ask on DTRX is now $30!
Took a pre-market position in TSPT 8.10, tight stop as always...
I do hope they eventually do become a success. Their pain medicine (cobroxin gel) is still letting me live a normal pain free life and I have stocked up on a few years supply.
Let's drive this lower with NITE and CSTI.
I remember those days very well. We studied those price actions in miners as a project in my final year in high school somewhere in Africa......
http://www.bloomberg.com/news/2011-11-30/gold-shares-cheapest-since-2002-are-coiled-spring-for-rally-commodities.html
Gold Shares Cheapest Since 2002 Are ‘Coiled Spring’ for Rally: Commodities
By Thomas Biesheuvel - Nov 30, 2011 10:19 AM ET
Gold miners’ earnings per share and per-share cash flow reached the highest levels in at least nine years during the third quarter, according to data compiled by Bloomberg. Photographer: Dadang Tri/Bloomberg
Nov. 28 (Bloomberg) -- Ned Naylor-Leyland, investment director at Cheviot Asset Management, talks about the outlook for gold prices. He speaks with Francine Lacqua on Bloomberg Television's "On the Move." (Source: Bloomberg)
Gold mining stocks are trading at their cheapest level in at least nine years even as the industry’s profits are estimated to almost double this year and bullion trades close to its historic high.
The benchmark NYSE Arca Gold BUGS Index (HUI) that includes Barrick Gold Corp. (ABX), Newmont Mining Corp. (NEM) and AngloGold Ashanti Ltd. ended last week at 17 times earnings, the lowest since at least November 2002 and below a five-year average of 37 times.
Investors sold equities across the board as Europe’s debt crisis soured the corporate profit outlook, and they’re ignoring analyst projections for bullion and gold producers. The gold index’s 16 members will increase combined per-share earnings 94 percent this year, according to estimates compiled by Bloomberg.
“When you look back in history, you will say this was a buying opportunity,” said John Wong, a portfolio manager at CQS Group’s New City Investment Managers in London and lead manager of the $200 million Golden Prospect Precious Metals Ltd., a fund holding gold and silver stocks. “It’s like a coiled spring.”
Gold equities have fallen 4.7 percent this year, heading for the first annual decline since 2008. Gold reached a record $1,921.15 on Sept. 6 and is set for an 11th annual gain.
“The market doesn’t trust big spikes,” said Jon Bergtheil, an analyst at Citigroup. “People will wait to see if gold holds above $1,600 for a while.”
‘Substantial Disconnect’
Gold averaged about $1,706 an ounce in the third quarter, 39 percent more than a year earlier, and is forecast to average $1,859 next year, according to the median estimate of 18 analysts compiled by Bloomberg. It gained 0.5 percent to $1706.74 at 10:49 a.m. London time.
Hedge fund manager David Einhorn said Nov. 1 that a “substantial disconnect has developed between the price of gold and the mining companies.” Einhorn’s Greenlight Capital Re cut holdings of the commodity in the third quarter and moved funds into the Market Vectors Gold Miners ETF, which tries to replicate the Arca Gold Miners Index (GDM) of metal producers. Bullion has more than doubled since the start of 2008 while gold stocks have advanced about 33 percent.
Gold miners’ earnings per share and per-share cash flow reached the highest levels in at least nine years during the third quarter, according to data compiled by Bloomberg.
“When earnings are reported, the market will be all goggle-eyed about how much cash is flowing in to these companies and what their balance sheets look like,” said Bergtheil. You tend to get a response at that time.’’
Debt Crisis
Gold equities have been dragged down as investors seek a haven from market turmoil stoked by the sovereign debt crisis. The MSCI All-Country World Index has fallen 12 percent this year while the Stoxx Europe 600 Index has sunk 16 percent.
Barrick Gold, the world’s biggest producer, has slipped 6.1 percent in 2011, even after posting record earnings in the third quarter. AngloGold Ashanti (ANG), Africa’s biggest supplier, has slipped 10 percent, while Newmont Mining has advanced 6.3 percent. Randgold Resources Ltd. (RRS) and Yamana Gold Inc. (YRI) are the only members of the Gold BUGS Index to have outperformed the metal this year, up 27 percent and 22 percent, respectively.
The Gold BUGS index today rose as much as 4.7 percent, the most in eight weeks.
Investors have been increasing holdings in exchange-traded products physically backed by gold to bet on gains in prices for the precious metal, without accepting the potential negatives that come with holding company shares.
Record Gold Hoard
“Investors are voting with their feet,” said Ian Preston, a resources analyst with Goldman Sachs Australia Pty in Melbourne. “They can get all of the leverage they want out of going straight into an ETF without any of the operational risk, or political risks, or general risks associated with equities.”
Holdings in gold ETFs on Nov. 23 reached a record 2,350.8 metric tons, valued at $127.6 billion, according to data compiled by Bloomberg. Hedge funds and other speculators increased their net-long position, or bets on higher prices, for four weeks, the longest stretch since March, Commodity Futures Trading Commission data show.
“Gold equities will come back,” Norm Pitcher, chief operating officer of Vancouver-based Eldorado Gold Corp. (ELD), said in an interview yesterday. “The one thing you don’t have when you are buying an ETF is any upside to exploration, and I think the companies that have good exploration assets are the ones that will probably be valued a little higher.”
That attraction of ETFs over stocks may also fade when concerns ease that the European debt crisis will ravage corporate profits, said New City’s Wong.
“Gold mining shares are still equities, so they are determined by the equity market as a whole, not just gold,” said Wong. “The performance of equities in a bear market is bad. Once there is some stability and people are prepared to take risks, I see that there will be a massive move.”
To contact the reporter on this story: Thomas Biesheuvel in London at tbiesheuvel@bloomberg.net
Printing presses screeeeeeeeaming......
I am just going to nibble here and there as it drifts down, I know how long these things take. Durning the winter my finger is never far from the trigger either. Making some good money on other plays so plenty in the old war chest.
PCFG spike down, now .0184..........
Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
http://ih.advfn.com/p.php?pid=nmona&article=50239771&symbol=NPHC
Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain Nutra Pharma announces the publication of their study outlining the mechanism of action of their pain drugs to be published in the journal Neuropharmacology.
PR Newswire
CORAL SPRINGS, Fla., Nov. 30, 2011
CORAL SPRINGS, Fla., Nov. 30, 2011 /PRNewswire/ -- Nutra Pharma Corporation (OTCBB: NPHC), a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, announced today that the journal Neuropharmacology will be publishing a mechanism study on the use of Alpha-Cobratoxin, a component of cobra venom, as a treatment for pain. The paper was co-authored by Paul Reid, PhD - the Chief Executive Officer of Nutra Pharma's wholly-owned subsidiary, ReceptoPharm and is available ahead of print on the journal's website or through the link: http://tinyurl.com/painmechanism.
"We are pleased to see continuing publications on the uses of cobra venom and cobra venom components," explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "This paper explains one of the proposed mechanisms involved in the relief of pain that we've seen with our venom-based therapeutics, Cobroxin and Nyloxin," he concluded.
Nutra Pharma currently produces three drugs for the treatment of pain: Cobroxin®, an over-the-counter pain reliever designed to treat moderate to severe (Stage 2) chronic pain; as well as Nyloxin™ and Nyloxin™ Extra Strength, stronger versions of Cobroxin®. These products are currently available in the United States as an oral spray for treating back pain, neck aches, headaches, joint pain, migraines, and neuralgia, and as a topical gel for treating joint pain, neck pain, arthritis pain, and pain from repetitive stress.
"Most of the published research conducted on the use of cobra venom as an analgesic took place decades ago," commented Dr. Paul Reid, CEO of ReceptoPharm. "We have been working diligently to bring the research up to date. While it is well-known that peptides from cobra venom could be used for the treatment of pain and inflammation, the mechanism has not been well-defined. The research in this paper provides a growing understanding of the mechanism of action in pain relief by Alpha-Cobratoxin," he concluded.
About Nutra Pharma Corp.Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin® and Nyloxin™. For additional information about Nutra Pharma, visit: http://www.NutraPharma.com
SEC DisclaimerThis press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The publication of this article should not be construed as an indication in any way whatsoever of the future value of the Company's common stock or its financial value. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
Printing 3.82 pre-market.
Printing 3.82 pre-market.
I am waiting for the gap to close for another ride.
Into the chitter it goes. Meet you all at .01.
WNYN has made some major changes this year and after watching this stock for about three years I would suggest accumulating it under one penny for a multiple penny gain down the road. I have put my money where my mouth is and continue to eat them under a penny.
HDY great call mate!!!!!!!!!
HDY weeeeeeee!
Would rather take those two than a kick in the n*ts with miners steel toed boot...
Management is sounding quiet confident in yesterdays news, I like it a lot.